According to Dipan Mehta the correction seen in pharma stocks on back of the geo-political issues in Ukraine is an opportunity to buy into because going forward too there is growth coming in for pharma cos from US and developed East-European markets
first published: Mar 4, 2014 12:49 pm
A collection of the most-viewed Moneycontrol videos.

Will Nifty Bulls March Towards Fresh Peak Despite Dismal Global Cues? | Opening Bell Live

Nifty Aims For Next 26,100 After Hitting 3-Week High |Opening Bell Live

Nifty Back Above 26,000 As IT Stocks Sprint Ahead; Nvidia Earnings In Focus| Closing Bell Live

Redefining Distribution with Next-Gen Technology Solutions
You are already a Moneycontrol Pro user.

